R SoRelle. Show Affiliations »
Abstract
Mesh: See more » Benzimidazoles/adverse effectsCalcium Channel Blockers/adverse effectsDrug ApprovalHumansHypertension/drug therapyMibefradilProduct Surveillance, PostmarketingTetrahydronaphthalenes/adverse effects
Substances: See more » BenzimidazolesCalcium Channel BlockersTetrahydronaphthalenesMibefradil
Year: 1998 PMID: 9738634 DOI: 10.1161/01.cir.98.9.831
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690